Metatron Announces Negotiations Underway For Acquisition Of A Colorado Based Cannabis Grower And CBD Oil Manufacturer
24 Julio 2017 - 5:30AM
InvestorsHub NewsWire
DOVER, DE -- July 24, 2017 --
InvestorsHub NewsWire -- Metatron (OTC
PINK: MRNJ), an emerging pioneer of releasing Marijuana &
CBD-related apps on iTunes and Google Play, is pleased to announce
it is in negotiations with a Colorado Grower and CBD oil
manufacturer. This Private Company grows quality Cannabis strains
specifically bred for high CBD output.
What we here at Metatron are looking
for and believe we have found is an organically grown raw product
high in CBD and other medicinal Cannabinoids and terpenes stated
CEO Joe Riehl. Our research has found that although Industrial Hemp
does indeed contain CBD oil, Hemp is actually grown for its fibrous
product and not CBD quality or potency, specific strain growth and
only the Flowering parts of the plant used as the source for the
CBD oils results in a purer high-quality CBD oil which has a much
greater medicinal value he added.
This acquisition will be determined
upon the final Due Diligence report and cost analysis factors, we
hope to be able to update shareholders in the near future on this
target as well as the previously announced deal in the July 18
Press Release said, Mr. Riehl.
Metatron has completed its new
Corporate website and updates and company information can be found
there. The completion of this website is just one more step in
Metatron moving towards being a major player in the Cannabis
Industry. Shareholders and potential investors can access the
website here http://metatroninc.com/
The company is also pleased to announce
a formal offer to Buzzlink, a cannabis e-commerce platform for
dispensaries and consumers. Buzzlink.com will be
financed partially by the issuance of preferred B series shares.
For more information, please visit http://metatroninc.com/series-b/ or http://www.metatronstock.com/.
Metatron approved investors can acquire
Series B shares in blocks of various sizes. The first round
investors will receive the highest discount. Series B shares can be
redeemed through the Company, are immune to reverse splits, and
will convert at 1 B share to 50,000 common shares. Details
available at http://metatroninc.com/series-b/ or http://www.metatronstock.com.
Metatron's Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog
Forward-Looking Statements:
Any statements made in this press
release which are not historical facts contain certain
forward-looking statements, as such term is defined in the Private
Litigation Reform Act of 1995, concerning potential developments
affecting the business, prospects, financial condition and other
aspects of the company to which this release pertains. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results
of the specific items described in this release, and the company's
operations generally, to differ materially from what is projected
in such forward-looking statements. Although such statements are
based upon the best judgments of management of the company as of
the date of this release, significant deviations in magnitude,
timing and other factors may result from business risks and
uncertainties including, without limitation, the company's need for
additional financing, which is not assured and which may result in
dilution of shareholders, the company's status as a small company
with a limited operating history, dependence on third parties and
the continuing popularity of the iOS operating system, general
market and economic conditions, technical factors, receipt of
revenues, and other factors, many of which are beyond the control
of the company. Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot
guarantee future results, levels of activity, performance, or
achievements. Moreover, neither we nor any other person assumes
responsibility for the accuracy and completeness of such
statements, and we disclaim any obligation to update information
contained in any forward-looking statement. Metatron does not grow,
sell or distribute any substances that violate United States Law or
the Controlled Substances Act.
Metatron, Inc.
Joe Riehl
302-861-0431
ir@metatroninc.com
SOURCE: Metatron, Inc.
Metatron (PK) (USOTC:MRNJ)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Metatron (PK) (USOTC:MRNJ)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024